Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03549715
Title NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma (NEMIO)
Acronym NEMIO
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Association Pour La Recherche des Therapeutiques Innovantes en Cancerologie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Hôpital Européen Georges Pompidou Paris Ile De France 75015 France Details
Hôpital Saint André, CHU de Bordeaux Bordeaux 33075 France Details
Sasu Roc37 Chambray Les Tours 37170 France Details
CHU Henri-Mondor Créteil 94000 France Details
Centre Leon Berard Lyon 69008 France Details
Institut Paoli Calmettes Marseille 13009 France Details
Centre Antoine Lacassagne Nice 06100 France Details
Groupe Hospitalier Pitié-Salpetrière Paris 75013 France Details
Institut Mutualiste Montsouris Paris 75014 France Details
Hôpital Cochin Paris 75679 France Details
Centre Eugène Marquis Rennes 35042 France Details
Hia Begin Saint-Mandé 94160 France Details
Hôpitaux universitaires de Strasbourg Strasbourg 67000 France Details
Institut Claudius Regaud Toulouse 31059 France Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field